Michael Richman serves as Executive at Opexa Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael Richman has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 16, 2017 involved selling 1,061 shares valued at $0.
Michael Richman currently holds 2,250 shares of Opexa Therapeutics, Inc. (OPXA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Richman has been a net neutral trader of OPXA stock. They have purchased $0 and sold $0 worth of shares.
Michael Richman's most recent insider trade was on Jun 16, 2017, when they sold 1,061 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 2,250 |
| $3.80 |
| Discretionary |
| Jun 16, 2017 | GNVC | $8.5K | Payment | 1,189 | $7.19 | Discretionary |
| Sep 30, 2016 | OPXA | $0 | Award | 6,455 | $N/A | Discretionary |
| Jun 30, 2016 | OPXA | $0 | Award | 6,455 | $N/A | Discretionary |
| May 16, 2016 | OPXA | $0 | Award | 6,455 | $N/A | Discretionary |
| Dec 31, 2015 | OPXA | $0 | Award | 1,354 | $N/A | Discretionary |
| Sep 30, 2015 | OPXA | $0 | Award | 1,200 | $N/A | Discretionary |
| Jun 30, 2015 | OPXA | $0 | Award | 8,427 | $N/A | Discretionary |
| Apr 8, 2015 | OPXA | $0 | Option Exercise | 8,242 | $N/A | Discretionary |
| Mar 31, 2015 | OPXA | $0 | Award | 6,818 | $N/A | Discretionary |
| Feb 28, 2014 | OPXA | $0 | Award | 8,242 | $N/A | Discretionary |